Is ABRYSVO registered in Botswana?

ABRYSVO is recorded with registration status “Registered/Compliant” in Botswana, registration number BOT2600183, based on BoMRA data.

Who manufactures ABRYSVO?

ABRYSVO is manufactured by Pfizer Manufacturing Belgium NV.

What is the active ingredient in ABRYSVO?

ABRYSVO contains Sodium chloride 1.10 mg/vial, dosage form Injection.

Registered Botswana · BoMRA

ABRYSVO

Sodium chloride 1.10 mg/vial

BOT2600183 Injection 1.10 mg/vial

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

BOT2600183

Registration date

2026-08-06

Expiry date

2031-08-05

Status

Registered/Compliant

Active ingredient

Sodium chloride 1.10 mg/vial

Dosage form

Injection

Strength

1.10 mg/vial

Pack size

Therapeutic class

Manufacturer / MAH

Pfizer Manufacturing Belgium NV

Applicant / LTR

PFIZER LABORATORIES Building 2 First Floor, Maxwell Office Park, Waterfall City, Midrand

Country of origin

Belgium

Manufacturer location

Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium

Source: Botswana Medicines Regulatory Authority · fetched 2026-09-25 04:32:44

Disclaimer: This information is sourced from Botswana Medicines Regulatory Authority (Botswana). Always consult a qualified healthcare professional before using any medication.